66
Participants
Start Date
May 31, 2002
Primary Completion Date
December 31, 2003
Study Completion Date
December 31, 2003
Ramelteon and Placebo (25 possible combinations total)
"Randomized sequence over two consecutive nights for a total of five treatment periods to include the following:~Ramelteon 4 mg, tablets, orally over two nights~Ramelteon 8 mg, tablets, orally over two nights~Ramelteon 16 mg, tablets, orally over two nights~Ramelteon 32 mg, tablets, orally over two nights~Ramelteon placebo-matching tablets, orally over two nights"
Lead Sponsor
Takeda
INDUSTRY